These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 10025774)

  • 1. Topiramate increases brain GABA, homocarnosine, and pyrrolidinone in patients with epilepsy.
    Petroff OA; Hyder F; Mattson RH; Rothman DL
    Neurology; 1999 Feb; 52(3):473-8. PubMed ID: 10025774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of gabapentin on brain GABA, homocarnosine, and pyrrolidinone in epilepsy patients.
    Petroff OA; Hyder F; Rothman DL; Mattson RH
    Epilepsia; 2000 Jun; 41(6):675-80. PubMed ID: 10840398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topiramate rapidly raises brain GABA in epilepsy patients.
    Petroff OA; Hyder F; Rothman DL; Mattson RH
    Epilepsia; 2001 Apr; 42(4):543-8. PubMed ID: 11440351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effects of vigabatrin on brain GABA and homocarnosine in patients with complex partial seizures.
    Petroff OA; Hyder F; Collins T; Mattson RH; Rothman DL
    Epilepsia; 1999 Jul; 40(7):958-64. PubMed ID: 10403220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain homocarnosine and seizure control of patients taking gabapentin or topiramate.
    Petroff OA; Hyder F; Rothman DL; Mattson RH
    Epilepsia; 2006 Mar; 47(3):495-8. PubMed ID: 16529611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homocarnosine and seizure control in juvenile myoclonic epilepsy and complex partial seizures.
    Petroff OA; Hyder F; Rothman DL; Mattson RH
    Neurology; 2001 Mar; 56(6):709-15. PubMed ID: 11274303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of vigabatrin on brain GABA+/CR signals in patients with epilepsy monitored by 1H-NMR-spectroscopy: responder characteristics.
    Mueller SG; Weber OM; Duc CO; Weber B; Meier D; Russ W; Boesiger P; Wieser HG
    Epilepsia; 2001 Jan; 42(1):29-40. PubMed ID: 11207782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vigabatrin increases human brain homocarnosine and improves seizure control.
    Petroff OA; Mattson RH; Behar KL; Hyder F; Rothman DL
    Ann Neurol; 1998 Dec; 44(6):948-52. PubMed ID: 9851440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localized 1H NMR measurements of 2-pyrrolidinone in human brain in vivo.
    Hyder F; Petroff OA; Mattson RH; Rothman DL
    Magn Reson Med; 1999 May; 41(5):889-96. PubMed ID: 10332870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homocarnosine and the measurement of neuronal pH in patients with epilepsy.
    Rothman DL; Behar KL; Prichard JW; Petroff OA
    Magn Reson Med; 1997 Dec; 38(6):924-9. PubMed ID: 9402193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated homocarnosine and GABA in subject on isoniazid as assessed through 1H MRS at 7T.
    Landheer K; Prinsen H; Petroff OA; Rothman DL; Juchem C
    Anal Biochem; 2020 Jun; 599():113738. PubMed ID: 32302606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human brain GABA levels rise rapidly after initiation of vigabatrin therapy.
    Petroff OA; Rothman DL; Behar KL; Collins TL; Mattson RH
    Neurology; 1996 Dec; 47(6):1567-71. PubMed ID: 8960747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low brain GABA level is associated with poor seizure control.
    Petroff OA; Rothman DL; Behar KL; Mattson RH
    Ann Neurol; 1996 Dec; 40(6):908-11. PubMed ID: 9007096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topiramate increases cerebral GABA in healthy humans.
    Kuzniecky R; Hetherington H; Ho S; Pan J; Martin R; Gilliam F; Hugg J; Faught E
    Neurology; 1998 Aug; 51(2):627-9. PubMed ID: 9710056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo.
    Rothman DL; Petroff OA; Behar KL; Mattson RH
    Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5662-6. PubMed ID: 8516315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of long-term vigabatrin therapy on selected neurotransmitter concentrations in cerebrospinal fluid.
    Ben-Menachem E; Persson LI; Mumford J; Haegele KD; Huebert N
    J Child Neurol; 1991; Suppl 2():S11-6. PubMed ID: 1719063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentration-effect studies with topiramate on selected enzymes and intermediates of the GABA shunt.
    Sills GJ; Leach JP; Kilpatrick WS; Fraser CM; Thompson GG; Brodie MJ
    Epilepsia; 2000; 41(S1):30-4. PubMed ID: 10768297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial observations on effect of vigabatrin on in vivo 1H spectroscopic measurements of gamma-aminobutyric acid, glutamate, and glutamine in human brain.
    Petroff OA; Rothman DL; Behar KL; Mattson RH
    Epilepsia; 1995 May; 36(5):457-64. PubMed ID: 7614922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of vigabatrin, lamotrigine, and topiramate on quantitative EEGs in patients with epilepsy.
    Neufeld MY; Kogan E; Chistik V; Korczyn AD
    Clin Neuropharmacol; 1999; 22(2):80-6. PubMed ID: 10202602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refractory epilepsy: treatment with new antiepileptic drugs.
    Datta PK; Crawford PM
    Seizure; 2000 Jan; 9(1):51-7. PubMed ID: 10667964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.